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Abstract
Background: Since constrictive pericarditis is most often idiopathic and the pathophysiology remains largely unknown,
both the diagnosis and the treatment can be challenging. However, by definition, inflammatory processes are central to
this disease process. Amniotic membrane patches have been shown to possess anti-inflammatory properties and are
believed to be immune privileged. Due to these properties, amniotic membrane patches were applied intraoperatively
in a complicated patient presenting with constrictive pericarditis.
Case presentation: A patient with a history of multiple cardiac surgeries presented with marked fatigue, worsening
dyspnea and sinus tachycardia. He was found to have constrictive physiology during cardiac catheterization, with cardiac
MRI demonstrating hepatic vein dilatation, atrial enlargement and ventricular narrowing. After amniotic membrane patch
treatment and pericardiectomy, post-operative cardiac MRI failed to demonstrate any appreciable pericardial effusion or
inflammation, with no increased T2 signal that would suggest edema.
Conclusions: Given the positive results seen in this complex patient, we suggest continued research into the beneficial
properties of amniotic membrane patches in cardiac surgery.
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Background
Constrictive pericarditis results in a thickened and less-
elastic pericardium, which can lead to incomplete dia-
stolic filling and myocardial ischemia [1]. Since it is
rare and the presenting symptoms are similar to those
of several other disorders, the diagnosis can often be
challenging. The diagnosis is usually made using car-
diac catheterization or echocardiography as a part of
the patient’s initial clinical evaluation. Although there
are multiple etiologies of constrictive pericarditis, in
most cases, the pathophysiology is idiopathic or may
occur following cardiac surgical procedures including
orthotopic heart transplant [2]. Constrictive pericarditis
is commonly treated with pericardiectomy; however
even following surgical intervention, long-term survival
decreases over time and further diminishes when pa-
tient history includes multiple cardiac re-operations [3].
It has recently been demonstrated that amniotic stem
cell therapy consisting of either stem cells with extra-
cellular matrix or extracellular matrix alone can de-
crease fibrosis and post operative inflammation in
humans [4, 5]. Specifically, extracellular matrix in the
form of human amniotic membrane allograft has shown
to significantly reduce post-ischemic cardiac dysfunc-
tion, improve ischemic heart repair, and increase blood
flow recovery in rat and mouse models [6, 7]. This
immunoprivileged tissue does not need to be donor-
recipient matched to produce positive outcomes, fur-
ther supporting its convenience of use and value [8]. In
the context of these anti-inflammatory properties, and
since inflammatory processes are central to the patho-
physiology of pericarditis, amniotic membrane patches
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were applied intraoperatively in a patient presenting
with constrictive pericarditis as outlined below.
Case presentation
A 34-year-old male had a history of orthotopic heart
transplant for hypertrophic obstructive cardiomyopathy
and subsequent tricuspid repair for severe tricuspid re-
gurgitation due to prolapse. The heart transplant was
performed at a medical center in a neighboring state,
with both prior surgeries performed by two different
surgeons. He was doing well for over 3 years following
these procedures, maintained with immunotherapy con-
sisting of 2.5 mg Prograf® BID and 250 mg CellCept®
daily as noted by the CT 7 Transplant Database. He then
developed a one-week history of marked fatigue, worsen-
ing shortness of breath, and sinus tachycardia on elec-
trocardiogram and was transferred to our facility from a
neighboring state. Upon arrival, the patient’s ejection
fraction was significantly reduced at less than 20%, com-
pared to his usual baseline of 60% last recorded 1.5 years
prior to this presentation. Given the concern for acute
transplant rejection, the patient underwent endomyo-
cardial biopsy via catheterization, which revealed evi-
dence of Grade 1R mild acute cellular rejection without
the presence of antibody-mediated rejection as
evidenced by a pathologic antibody-mediated rejection
(pAMR) of 0. Hemodynamic findings from right and left
cardiac catheterization revealed equalization of diastolic
filling pressures with discordance after volume loading,
consistent with constrictive physiology. Additionally, Frei-
dreich’s sign was present with both steep x and y descent
of the jugular venous pressure (JVP) tracing with in-
creased left and right ventricular diastolic pressures with
dip and plateau (square root sign). The patient then
underwent a cardiac magnetic resonance imaging (MRI)
study to further evaluate the constrictive physiology. Car-
diac MRI revealed mild pericardial thickening, mild flat-
tening and bounce of the interventricular septum,
intermediate epicardial signal on pre-contrast T2-
weighted images and demonstrated intermediate delayed
enhancement with post-contrast T1-weighted images con-
sistent with fibrotic tissue (Fig. 1a, b). There was also
moderate to moderate-severe tricuspid regurgitation.
Given the hemodynamic values from cardiac
catheterization and pericardial thickening, surgery was
recommended to replace the tricuspid valve and remove
the fibrotic epicardial material.
Using a redo sternotomy approach, complete phrenic
to phrenic pericardiectomy, removal of Gore-Tex mem-
brane from previous surgery and a tricuspid valve
Fig. 1 Post-contrast T1-weighted cardiac MRI images. Preoperative MRI short-axis (a) and 2-, 3-, and 4-chamber long axis (b) delayed-enhanced
inversion-recovery images demonstrate pericardial thickening and epicardial enhancement (arrows) with subtle periventricular septal flattening.
On dynamic cine imaging and anatomic imaging (not shown) there is septal bounce during Valsalva suggesting ventricular inter-dependance
and biatrial enlargement with dilated IVC and hepatic veins. These findings are absent on postoperative cardiac MRI (c-d)
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replacement were completed. Gross intraoperative find-
ings of the pericardial space included thick, gelatinous
material on the anterior surface of the heart, and the peri-
cardium and Gore-Tex membrane were fused to the
thickened pericardium on the anterior surface of the heart.
(Fig. 2a) Prior to closure, four human allograft membranes
were topically placed over the right atrium, right ventricle
and left ventricle (Fig. 2b) for their anti-fibrotic and anti-
inflammatory properties [7, 8]. The surgical pathology
report later confirmed fibrosis of the explanted tricuspid
valve, pericardial fibrosis, and chronic pericardial inflam-
mation. Though constrictive physiology was still noted,
post-contrast T1-weighted cardiac MRI images demon-
strate significant improvement (Fig. 1c, d). Furthermore, a
five-week postoperative fat-suppressed T2-weighted MRI
revealed no appreciable postoperative inflammation and
an absence of pericardial effusion (Fig. 3).
Discussion
Constrictive pericarditis is difficult to diagnose given its
rare occurence and that the presenting symptoms are
similar to those of several other disorders. In our patient,
this diagnosis was further complicated by his history of
orthotopic heart transplant. While the techniques con-
tinue to evolve, imaging patients in order to optimize
diagnosis following cardiac transplant is limited [9].
Given our patient’s surgical history and clinical presenta-
tion, the constrictive physiology from cardiac
catheterization was considered to be a more reliable
diagnostic measure than both the MRI and echocardio-
gram findings. The case discussed serves as a prime ex-
ample for the need to develop alternate non-invasive
imaging techniques or algorithms for improved diagnos-
tic capacity in patients with prior orthotopic heart
transplant.
Another confounding variable in diagnosing constrictive
pericarditis in our patient was the steep y descent on JVP.
Although Freidreich’s sign is suggestive for constrictive
pericarditis, our patient was also diagnosed with severe
tricuspid regurgitation. However, despite these diagnostic
difficulties, the patient was known to have prior Gore-Tex
membrane placement during surgery. This iatrogenic
component is another factor that may, in part, explain his
constrictive physiology.
As discussed previously, pericardiectomy is often per-
formed as a curative procedure for constrictive pericar-
ditis. However there are instances, particularly for
patients with advanced constrictive pericarditis or with
radiation disease, in which pericardiectomy may not
offer a cure or desired long-term result [1]. For these
Fig. 2 Intraoperative images. Thick gelatinous material was found on the anterior surface of the heart, with the pericardium and Gore-Tex
membrane fused to the thickened pericardium at the anterior surface (a). Four human allograft membranes were topically placed over the
right atrium, right ventricle, and left ventricle (b) for their anti-fibrotic and anti-inflammatory properties
Fig. 3 T2 Fat Sat Horizontal long-axis fat-suppressed T-2 weighted images. Preoperative cardiac MRI (a) reveals hepatic vein dilatation, atrial
enlargement and ventricular narrowing (arrows). Post-operative cardiac MRI (b) fails to demonstrate any appreciable pericardial effusion or
inflammation, with no increased T2 signal that would suggest edema (arrows)
Marsh et al. Journal of Cardiothoracic Surgery  (2017) 12:6 Page 3 of 4
patients with higher risk factors, it may be beneficial to
explore additional or alternative treatment options.
Current treatment of recurrent pericarditis has focused
on targeting inflammation, and has shown overall posi-
tive outcomes [3]. Given our patient’s extensive cardiac
history of orthotopic heart transplant, reoperation for
tricuspid valve repair, and Gore-Tex adhesions, extraor-
dinary care was initiated in an attempt to resolve his con-
strictive pericarditis. As an emerging anti-inflammatory
and anti-fibrotic treatment, the use of human allograft
membrane has proven to be both safe and effective in
humans thus far and continues to pique interest as an
alternative therapy option [7, 8]. The anti-inflammatory
properties of this treatment were exemplified, as our
patient had no evidence of inflammation notable on T2-
weighted MRI five weeks postoperatively (Fig. 3b). Given
the positive results, we suggest continued research into
the beneficial properties of amniotic membrane patches in
cardiac surgery.
Conclusion
Constrictive pericarditis is difficult to treat, and even a
pericardiectomy may not offer a cure or desired long-
term result. Given the inflammatory processes central to
this disease process, amniotic membrane patches were
used as anti-inflammatory treatment in a patient with a
complicated history. With the amniotic membrane patch
treatment and pericardiectomy, our patient had no evi-
dence of inflammation five weeks postoperatively on T2-
weighted MRI, highlighting the importance of continued
research in this area.
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